FindTrial
Sign In

The Study to Develop the Guiding Principle of Diabetes Management Aiming to Prevent the Progression of Dementia: A Proposal on the Basis of the Systematic Review

The Study to Develop the Guiding Principle of Diabetes Management Aiming to Prevent the Progression of Dementia: A Proposal on the Basis of the Systematic Review - The Study to Develop the Guiding Principle of Diabetes Management Aiming to Prevent the Progression of Dementia: A Proposal on the Basis of the Systematic Review

Status
Recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000042499
Enrollment
Unknown
Registered
2020-11-30
Start date
2020-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

None listed

Sponsors

National Hospital Organization Kyoto Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: I. Intervention study (Review questions 1) a) PICOS: Patient: Type 2 diabetes Intervention: i) Drugs (hyperglycemic drugs, antihypertensive drugs, dyslipidemia drugs, antiplatelet drugs) ii) Exercise, leisure, depression iii) Diet (dietary nutrients, vitamins, supplements, drinking) Comparison: Normal medical care group Outcome: i) Cognitive decline, ii) Onset of dementia b) Intervention / follow-up period: intervention period of 3 months or more, follow-up period of 3 months or more c) Presentation language: English, Japanese II. Observational studies (Review questions 2) a) CQ: Predictive biomarker of cognitive decline in type 2 diabetes, MCI or dementia b) Follow-up period: 6 months or more c) Presentation language: English, Japanese Search data sources: PubMed / MEDLINE, The Cochrane Library, Ichushi Web

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
1) Cognitive decline 2) Onset of dementia—

Countries

Japan

Contacts

Public ContactNoriko Satoh-Asahara

National Hospital Organization Kyoto Medical Center Department of Endocrinology, Metabolism and Hypertension Research, Clinical Research Institute

nsatoh@kuhp.kyoto-u.ac.jp075-641-9161

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026